Elevalue Laboratories

Executive Summary

Elevalue Laboratories is a specialized contract research organization (CRO) founded in 2021 and headquartered in San Francisco, offering end-to-end analytical and bioassay development services for the cell and gene therapy (CGT) sector. The company supports clients from early development through IND and BLA submissions, leveraging a suite of phase-appropriate assay platforms and validation strategies. By focusing exclusively on the rapidly growing CGT market, Elevalue addresses a critical need for reliable, outsourced bioanalytical services that can accelerate therapeutic timelines.

Upcoming Catalysts (preview)

• Q4 2026Major partnership or service contract with a leading CGT developer40% success
• Q2 2027Expansion of assay platform portfolio (e.g., ddPCR, flow cytometry, ELISA)50% success
• Q1 2027Successful support of a client’s IND or BLA filing, demonstrating regulatory expertise35% success